Health regulators in the United States recommended a temporary halt in the use of Johnson & Johnson’s COVID-19 vaccine due to reported blood clot cases, the WSJ reported.
- The announcement was made by the Food and Drug Administration and the Center for Disease Control and Prevention.
- Six women between the ages of 18 and 48 inoculated with the J&J vaccine reportedly developed blood clots. Over 6.8 million doses of the vaccine have been administered in the U.S.
- Outside experts will meet to review the matter for the CDC on Wednesday, while the FDA will also conduct an investigation.
- The agencies said individuals vaccinated with J&J’s vaccine should notify their doctor if they develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination.
- Clinics administering the J&J vaccine in North Carolina, Colorado, and Georgia have closed temporarily in recent weeks after some individuals who received the shot experienced adverse effects.